Covid-19: Race for Indian vaccine hots up, human trials on in 6 cities

Both BB and Zydus were granted permission for Phase I and II clinical trials and administered the first doses of their vaccine candidates to volunteers on July 15. A third vaccine candidate, developed by Oxford University, is soon to be tested in India. Serum Institute, which is in a manufacturing partnership with the UK’s Astra Zeneca, has said it will begin human trials as soon as it receives regulatory approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hxh5NY
via IFTTT